Last edited by Temuro
Monday, April 20, 2020 | History

6 edition of Stability and characterization of protein and peptide drugs found in the catalog.

Stability and characterization of protein and peptide drugs

case histories

by

  • 175 Want to read
  • 35 Currently reading

Published by Plenum Press in New York .
Written in English

    Subjects:
  • Protein drugs -- Stability,
  • Peptide drugs -- Stability,
  • Proteins -- pharmacokinetics,
  • Proteins -- chemistry,
  • Peptides -- pharmacokinetics,
  • Peptides -- chemistry,
  • Drug Stability

  • Edition Notes

    Includes bibliographical references and index.

    Statementedited by Y. John Wang and Rodney Pearlman.
    SeriesPharmaceutical biotechnology ;, v.5
    ContributionsWang, Y. John., Pearlman, Rodney.
    Classifications
    LC ClassificationsRS431.P75 S69 1993
    The Physical Object
    Paginationxxi, 353 p. :
    Number of Pages353
    ID Numbers
    Open LibraryOL1399776M
    ISBN 100306443651
    LC Control Number93007490

    AAPS Short Course: Characterization Methods for Aggregates and Particles in Peptide and Small Protein Formulations • To explore and identify analytical methods to characterize aggregation and fibrillation in peptide formulations. • To provide a collaborative, cross-disciplinary forum for scientific discussion.


Share this book
You might also like
Harpers Weekly October 8, 1864

Harpers Weekly October 8, 1864

Modeling the effect of competition on tree diameter growth as applied in stems

Modeling the effect of competition on tree diameter growth as applied in stems

Cannibal nights

Cannibal nights

Fundamentals of chemical reaction engineering

Fundamentals of chemical reaction engineering

Native American fiction

Native American fiction

The real story

The real story

archaeological study of the Timmeron Rockshelter (41 HY 95), Hays County, South Central Texas

archaeological study of the Timmeron Rockshelter (41 HY 95), Hays County, South Central Texas

Composition of international capital flows

Composition of international capital flows

Birding in Venezuela

Birding in Venezuela

Stability and characterization of protein and peptide drugs Download PDF EPUB FB2

Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology (5)): Medicine & Health Science Books @ 5/5(1). Stability and Characterization of Protein and Peptide Drugs Case Histories.

Editors (view affiliations) Stability Characterization and Formulation Development of Alteplase, a Recombinant Tissue Stability and characterization of protein and peptide drugs book Activator DNA development drugs pharmaceutical protein proteins research. Editors and affiliations.

John Wang. 1; Rodney. Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability.

This ready reference also features recent data and an. Stability and Characterization of Protein and Peptide Drugs by Rodney Pearlman,available at Book Depository with free delivery worldwide.

Stability and Characterization of Protein and Peptide Drugs | This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar- keted or are under clinical testing.

In previous volumes of this series, funda- mental theories and principles ofprotein characterization and stability were presented in depth. Stability and Characterization of Protein and Peptide Drugs Case Histories Edited by Y. John Wang Scios Nova, Inc.

Mountain View, California and Rodney Pearlman Genentech, Inc. South San Francisco, California Plenum Press • New York and LondonCited by: Nguyen TH, Ward C () Stability characterization and formulation development of Alteplase, a recombinant tissue type plasminogen activator. In: Wang YJ, Pearlman R (eds) Stability and characterization of protein and peptide drugs: Case Histories, Plenum Press, New York, pp 91 – Google ScholarAuthor: C.

Middaugh, R. Pearlman. Stability and Characterization of Protein and Peptide Drugs Case Histories. Editors: Pearlman, Rodney, Stability and characterization of protein and peptide drugs book, Y.

John (Eds.) Free Preview. Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology) and a great selection of related books, art. ISBN: OCLC Number: Description: xxi, pages: illustrations ; 24 cm: Contents: Stability and characterization of human growth hormone / Rodney Pearlman and Thomas A.

Bewley --Characterization and formulation considerations for recombinantly derived bovine somatotropin / Stephen R. Davio and Michael J. Hageman. Find helpful customer reviews and review ratings for Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology) at Read honest and unbiased product reviews from our users.5/5.

This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar­ keted or are under clinical testing. In previous volumes of this series,funda­ mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise.5/5(1).

Parenteral formulations of proteins and peptides: stability and stabilizers Article (PDF Available) January with 1, Reads How we measure 'reads'. Protein Characterization. We provide a Stability and characterization of protein and peptide drugs book range of high-quality analytical assays to characterize protein therapeutics.

Whether characterizing the original or subsequent reference standards, evaluating production lots to those standards or performing comparability studies of biosimilars or biobetters, we have the full-range of. Get this from a library. Stability and characterization of protein and peptide drugs: case histories.

[Y John Wang; Rodney Pearlman;] -- This is Stability and characterization of protein and peptide drugs book first volume to make available specific case histories of therapeutic proteins and peptides that have been marketed or are currently under clinical testing.

The editors have selected a. Rodney Pearlman is the author of Formulation, Characterization, and Stability of Protein Drugs ( avg rating, 2 ratings, 0 reviews, published ), S 3/5(2). Title: Stability and Characterization of Protein and Peptide Drugs: Case Histories Format: Hardcover Product dimensions: pages, X X 0 in Shipping dimensions: pages, X X 0 in Published: Publisher: Kluwer Boston Inc.

Language: English. Additionally, the paper provides an overview of recent studies on characterization of solid drug carriers for peptide/protein drugs, drug distribution in particles, drug release and stability in simulated GI fluids, as well as the absorption of peptide/protein drugs in cell-based models.

Peptides and proteins are subjected to chemical degradation in much the same way as low molecular weight drugs.

In addition, peptides and proteins can be subjected to physical degradation (i.e., alteration of their higher order structures (Fig. The primary protein structure refers to the amino acid sequence of the polypeptide chain.

Buy the Paperback Book Stability and Characterization of Protein and Peptide Drugs: Case Histories by Rodney Pearlman atCanada's largest bookstore. Free shipping and pickup in store on eligible orders. disease. This book gives practical advice to the most important steps in peptide-based drug development such as isolation, purification, characterization, interaction with targets, struc-tural analysis, stability studies, assessment of biodistribution and pharmacological param-eters, sequence modifications, and high throughput screening.

Protein Stability and Characterization. is widely used in the characterization of biomolecules including peptide and protein therapeutics. Native ESI MS also allows the interactions of Author: Atanas Koulov. Leading scientists offer detailed profiles of ten protein drugs currently in development.

The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information.

The in-depth coverage includes a highly. Pharmaceutical development of peptide and protein drugs presents new problems in the area of stability assessment.

Generally, these products require more analytical effort than more classic drugs; this may even dictate the speed of progress in certain development by: 5. Protein Analytical Service REQUEST NOW With world-class analytical techniques, GenScript is proud to provide a wide range of analytical testing services to ensure product quality and consistency during all stages of drug discovery and development.

Although each chapter in this volume focuses primarily on the charac- terization and stability of a specific molecule, each has unique aspects. Pharmaceutical Biotechnology: Stability and Characterization of Protein and Peptide Drugs: Case Histories (Hardcover)Brand: Rodney Pearlman.

Stability and Characterization of Protein and Peptide Drugs: Case Histories (Inglés) Pasta dura – 31 may por Rodney Pearlman (Editor), Y John Wang (Editor) de 5 estrellas 1 calificación. Ver todos los 3 formatos y ediciones Ocultar otros formatos y ediciones 5/5(1).

Unlimited ebook acces Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology) full ebook Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology)|acces here Stability and Characterization of Protein and Peptide Drugs: Case Histories.

sionals working on Innovator and Biosimilar Protein and Peptide stability during development, for ap-proval, and for postmarketing studies. Because of lives of Innovator and Biosimilar protein and pep - tide drugs. Product characterization activities • Reading a protein or peptide structure. Protein Formulation and Delivery - CRC Press Book 1.

Overview of Protein Formulation and Delivery 1 James Wright 2. Chemical Considerations in Protein and Peptide Stability 7 Paul M. Bummer 3. Physical Considerations in Protein and Peptide Stability 43 Sandy Koppenol 4.

Temperature Dependence of the Degradation Rate of Peptide and Protein Drugs • Stability prediction for peptide and protein drugs under accelerated testing conditions is possible if the temperature dependence of the degradation rate is.

There are several protein and peptide drugs which are approved by the FDA listed in Table 1. The advent of biotechnology and modern analytical tools has promoted discovery and large scale production of protein and peptide drugs.

Peptide is a short chain of amino acid residues with a defined sequence (e.g. Leuprolide). Protein is polypeptides Author: L. Srinivas, V. Manikanta, M. Jaswitha. Protein targets for potential peptide drugs. New peptide drugs are currently under development for a variety of protein targets. Here we focus on three major disease states, namely HIV infection, cancer and Alzheimer’s disease and discuss some of the ongoing research toward the design and development of peptide drugs against these by: 6.

Title:Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance VOLUME: 25 ISSUE: 6 Author(s):Huizi Wu* and Jiaguo Huang* Affiliation:Department of Pharmacy, Xiangya Hospital, Central South University, ChangshaMedical Research Center, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, Cited by: 2.

peptide and protein drug analysis Download peptide and protein drug analysis or read online books in PDF, EPUB, Tuebl, and Mobi Format. Click Download or Read Online button to get peptide and protein drug analysis book now.

This site is like a library, Use search box in the widget to get ebook that you want. A chemical modification of peptide and protein drugs improves their enzymatic stability and/or membrane penetration of peptides and proteins.

It can also be used for minimizing immunogenicity. Protein modification can be done either by direct modification of exposed side-chain amino acid groups of proteins or through the carbohydrate part of.

This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar- keted or are under clinical testing. In previous volumes of this series, funda- mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise.

The way from. Characterization, and Stability of Protein Drugs Case Histories Edited by Stability, Characterization, Formulation, and Delivery System Primary Structure—Peptide Map Secondary and Tertiary Structures Dimerization of Recombinant Human Relaxin File Size: KB.

Peptides and proteins have great potential as therapeutics. Currently, the market for peptide and protein drugs is estimated to be greater than US$40 billion/year, or 10% of the pharmaceutical market [].This market is growing much faster than that of small molecules, and will make up an even larger proportion of the market in the future [].At present there are over approved Cited by: a solid understanding of the most common mechanisms of protein degradation; an overview of where pharmaceutical proteins are most likely to be damaged during bioprocessing and storage the physical basis for the aggregation and solubility behaviour of polypeptides.

1. Manning MC, Patel K and Borchardt RT, Stability pdf protein pharmaceuticals, Pharm Res, 6, pp, 2. Pdf EM, Zhang L, Zhao H et al, Chemical instability in peptide and protein pharmaceuticals, Formulation and Process Development Strategies for Manufacturing of a Biopharmaceutical(Jameel F, Hershenson S (eds), Wiley and Sons, New York.

Chemical instability Involves alteration in the molecular structure producing a new chemical entity, by bond formation or cleavage. The stability of peptide and proteins against a chemical reagent is decided by temperature, length of exposure, and the amino acid composition, sequence and conformation of the peptide/protein.

Ahern, T. J. & Manning, M. C. (eds) Ebook of Protein Pharmaceuticals — Part A: Chemical and Physical Pathways of Protein Degradation Pharmaceutical Biotechnology Series Vol.

2 (Plenum, New Cited by: